I now have all the material needed for a comprehensive, well-illustrated response. Let me compose it.
Sickle Cell Disease: Basics & Orthopaedic Complications
Part I — Basics of Sickle Cell Disease
1. Definition & Genetics
Sickle Cell Disease (SCD) is a group of autosomal recessive haemoglobinopathies caused by a point mutation in the β-globin gene on chromosome 11. The substitution of valine for glutamic acid at position 6 of the β-globin chain produces haemoglobin S (HbS). Under deoxygenated conditions, HbS polymerises into long rigid rods, distorting the red cell into a characteristic sickle shape.
Genotypes and clinical severity:
| Genotype | Condition | Severity |
|---|
| HbSS | Sickle cell anaemia | Most severe |
| HbSC | Sickle-haemoglobin C disease | Moderate; paradoxically more bone infarction |
| HbS-β-thal | Sickle-β-thalassaemia | Can equal HbSS severity |
| HbSA | Sickle cell trait | Usually asymptomatic; rare crises |
"If the second β-chain is also HbS, then the patient has homozygous HbS-S, defined as sickle cell anaemia."
— Grainger & Allison's Diagnostic Radiology, p. 1717
2. Epidemiology
- Primarily affects people of sub-Saharan African origin; also Middle East, Mediterranean, India
- ~8–10% of Black Americans carry sickle cell trait; ~0.2% have sickle cell anaemia
- Homozygous SCD reduces average life expectancy by 25–30 years (most patients die by age 50)
- The HbS gene confers relative protection against Plasmodium falciparum malaria — explaining its high frequency in malaria-endemic regions
3. Pathophysiology
Step-by-step mechanism:
Fig 1: HbS polymerisation cascade leading to sickling and vaso-occlusion
- HbS polymerisation: On deoxygenation, HbS forms long polymeric fibres → distorts RBC into rigid, sickle shape
- Reversibility: Early sickling is reversible on reoxygenation; repeated cycles cause irreversible membrane damage
- Shortened RBC lifespan: Sickled cells survive only ~1/10th normal lifespan (~10–20 days vs. 120 days) → chronic haemolytic anaemia
- Vaso-occlusion: Rigid sickled cells obstruct small blood vessels → stasis → hypoxia → infarction
- Oxidative cascade: HbS auto-oxidation generates reactive oxygen species (ROS), free haem, and iron → endothelial injury, NO depletion, coagulation activation, thrombosis
Fig 2: Oxidative stress cascade in SCD — from HbS polymerisation to SCD vascular pathology
Peripheral blood smear shows the classic mixture of sickle cells, target cells, polychromasia, and nucleated RBCs:
Fig 3: Peripheral blood smear — sickle cells interspersed with normal and target RBCs (Harrison's Principles of Internal Medicine)
4. Precipitating Factors for Sickling Crisis
- Hypoxia (high altitude, anaesthesia, poor ventilation)
- Dehydration
- Cold exposure / temperature extremes
- Infection / fever
- Acidosis
- Stress (physical or emotional)
- Strenuous exercise
5. General Clinical Manifestations (Non-Orthopaedic)
| System | Manifestation |
|---|
| Blood | Haemolytic anaemia (Hb 6–9 g/dL), jaundice, cholelithiasis |
| Spleen | Functional asplenia (autosplenectomy by adulthood); acute sequestration in children |
| Lung | Acute chest syndrome (commonest cause of death) |
| CNS | Stroke, silent cerebral infarcts |
| Kidney | Papillary necrosis, nephrotic syndrome, renal failure |
| Eye | Proliferative retinopathy, vitreous haemorrhage |
| Skin | Chronic leg ulcers (medial malleolus) |
| Priapism | Vaso-occlusion in penile vasculature |
Part II — Orthopaedic Complications of Sickle Cell Disease
The orthopaedic manifestations of SCD arise primarily from three mechanisms:
SCD Bone Pathology
│
├── 1. Bone Infarction (vaso-occlusion)
│ ├── Dactylitis (infants)
│ ├── Diaphyseal infarction (metaphysis/epiphysis)
│ └── Osteonecrosis (AVN)
│
├── 2. Marrow Hyperplasia
│ ├── Widened medulla / cortical thinning
│ ├── H-shaped vertebrae
│ └── Osteopenia / pathological fractures
│
└── 3. Osteomyelitis (secondary to infection)
└── Salmonella >> Staphylococcus aureus
Harrison's Principles, Table 386-1; Grainger & Allison's Diagnostic Radiology, p. 1717
Orthopaedic Complication 1: Sickle Cell Dactylitis (Hand-Foot Syndrome)
Definition: Infarction of the bone marrow and cortical bone of the small tubular bones of the hands and feet, resulting in periostitis and soft tissue swelling.
Who gets it: ~50% of infants with SCD between 6 months and 2 years of age; rare after 6 years (when the red marrow of small bones is replaced by fatty marrow, removing the sickling substrate).
Signs & Symptoms:
- Pain, swelling, and warmth of the fingers and/or toes
- Fever (can mimic infection)
- Tender swollen digits
- Lasts 1–3 weeks; resolves without residual damage in most cases
- Asymmetrical shortening of tubular bones is a common long-term sequela
Radiology:
- Early: soft-tissue swelling only
- Later: periosteal elevation, subperiosteal new bone, lytic lesions (bone destruction), irregular cortex
- These changes resolve over months
Fig 4: Sickle cell dactylitis — bone destruction at multiple metacarpals and proximal phalanges (white arrows), with soft tissue swelling (Grainger & Allison's, p. 1718)
Treatment: Analgesia, hydration, warmth; antibiotics if infection cannot be excluded. Usually self-limiting.
Orthopaedic Complication 2: Bone Infarction & Vaso-Occlusive Bone Crisis
Pathophysiology: Vaso-occlusion by sickled cells in nutrient vessels → ischaemia → medullary and cortical bone necrosis. Bone infarction is at least 50 times more common than osteomyelitis in SCD.
Sites:
- Children: predominantly diaphysis of long bones
- Adolescents/Adults: metaphyses and epiphyses (→ AVN)
- Ribs/sternum: simulate cardiopulmonary disease
- Vertebrae: central end-plate infarction → "H-shaped" vertebra (~10% of patients)
Signs & Symptoms:
- Severe, deep, constant bone pain (most common reason for hospitalisation)
- Localised tenderness and swelling over affected bone
- Low-grade fever
- Joints may show effusion (periarticular involvement)
- Knees and elbows most commonly affected
Vertebral Involvement — "H-Shaped Vertebra":
Venous thromboembolism in the centre of the vertebral end plate causes focal collapse → central depression → the vertebral body acquires a squared-off "H" or "Lincoln log" shape, almost pathognomonic of SCD:
Fig 5: "H-shaped" vertebrae — stepped central depression of multiple lumbar vertebral end plates (white arrows); adjacent "tower" vertebra (arrowhead). (Grainger & Allison's, Fig. 66.15)
Orthopaedic Complication 3: Osteonecrosis / Avascular Necrosis (AVN)
The single most devastating orthopaedic complication of SCD.
Epidemiology:
- ~50% of all SCD patients develop osteonecrosis by age 35
- SCD is the most common cause of osteonecrosis of the femoral head in children
- AVN of the femoral head occurs in ~5% of patients with HbSS
- Paradoxically more common in HbSC (5× more frequent than HbSS, likely due to longer survival)
- Bilateral involvement is frequent
Sites (in order of frequency):
- Femoral head (most common)
- Humeral head
- Distal femur, tibial condyles
- Distal radius
- Vertebral bodies
Pathophysiology: Repeated or sustained vaso-occlusion of the terminal blood supply to the epiphysis → ischaemic death of subchondral bone → subchondral fracture → articular collapse → secondary osteoarthritis.
Signs & Symptoms:
- Insidious onset of pain in groin / hip / shoulder
- Pain worsened by weight bearing and movement
- Reduced range of motion (esp. internal rotation of hip)
- Antalgic gait
- Eventually severe joint destruction with deformity
Investigations:
| Modality | Findings |
|---|
| Plain X-ray | Early: normal or subtle sclerosis; Later: patchy radiolucency + sclerosis, subchondral fracture (crescent sign), femoral head collapse, secondary OA |
| MRI (gold standard) | Earliest changes: epiphyseal oedema on STIR (bright signal); T1: low signal fracture line; double-line sign pathognomonic |
| Bone scan | Increased uptake; less specific |
| CT | Confirms subchondral fracture, extent of collapse |
Fig 6: AVN of the right femoral head in SCD — femoral head collapse with patchy lysis and sclerosis (arrow). (Grainger & Allison's, Fig. 66.16)
Fig 7: Bilateral femoral head AVN in SCD — advanced bilateral osteonecrosis with femoral head collapse, sclerosis, and secondary OA
Fig 8: AVN of the humeral head in SCD — epiphyseal sclerosis (arrow) and endosteal sclerosis with narrowing of the medullary cavity (arrowhead). (Grainger & Allison's, Fig. 66.18)
Ficat & Arlet Staging of Femoral Head AVN:
| Stage | Findings |
|---|
| I | Normal X-ray; abnormal MRI (bone marrow oedema) |
| II | Sclerosis/cysts; preserved spherical head |
| III | Subchondral fracture (crescent sign); flattening begins |
| IV | Femoral head collapse; secondary OA |
Treatment of AVN:
| Stage | Treatment |
|---|
| Early (I–II) | Protected weight bearing; analgesia; physiotherapy; consider core decompression |
| Core decompression | Drilling channels in femoral head to decompress venous hypertension and allow revascularisation; best in Stage I–II |
| Vascularised fibula graft | For Stage II–III in young patients |
| Osteotomy | Rotate necrotic segment away from weight-bearing zone |
| Total Hip Arthroplasty (THA) | Stages III–IV; definitive treatment but technically demanding in SCD due to narrow medullary canal, osteosclerosis, and immunocompromise |
Fig 9: Femoral head AVN (A) treated with total hip arthroplasty (B) — the definitive surgical option for Ficat Stage III–IV
Orthopaedic Complication 4: Osteomyelitis
Unique features in SCD (different from general osteomyelitis):
- Prevalence in SCD: ~18%
- Affects long bone diaphyses (not the metaphysis as in typical childhood osteomyelitis)
- Most common organism: Salmonella spp. (~60–70%) — microinfarcts in bowel allow Salmonella bacteraemia to seed bone
- Second most common: Staphylococcus aureus (~10%)
- Often multifocal
- Mechanism: splenic dysfunction → impaired opsonisation → haematogenous seeding; infarcts provide necrotic substrate for bacterial adhesion
Signs & Symptoms:
- Fever, toxicity, high WBC (more prominent than in bone infarction)
- Localised bone pain, tenderness, swelling
- Often clinically indistinguishable from bone infarction (the "great mimicker")
Key distinction: Osteomyelitis vs. Bone Infarction
| Feature | Osteomyelitis | Bone Infarction |
|---|
| Fever | High, persistent | Low-grade or absent |
| ESR/CRP | Markedly elevated | Mildly elevated |
| WBC | Markedly elevated | Mildly elevated |
| Response to analgesia | Poor | Improves in 24–48 hours |
| Plain X-ray | Periosteal reaction, lytic destruction | Normal early; sclerosis later |
| MRI | Geographical marrow enhancement post-contrast; cortical defect with abscess | Serpentine enhancement; no cortical defect |
| Bone scan | Hot in all 3 phases | May be cold (photopenic) early |
Treatment:
- Empiric IV antibiotics covering Salmonella + S. aureus: vancomycin + ciprofloxacin (or third-generation cephalosporin)
- Surgical drainage if abscess or sequestrum
- Bone biopsy and culture before antibiotics if possible
Orthopaedic Complication 5: Septic Arthritis
- Prevalence ~7% in SCD
- Haematogenous seeding from bacteraemia (splenic dysfunction) or contiguous osteomyelitis
- Multiple joints may be infected simultaneously
- Common organisms: S. aureus, Streptococcus (Salmonella causes osteomyelitis far more often than septic arthritis)
- Signs & Symptoms: Hot, swollen, tender joint; restricted ROM; fever; joint effusion with high neutrophil count
- Treatment: Urgent joint aspiration/washout + IV antibiotics
Orthopaedic Complication 6: Marrow Hyperplasia & Skeletal Changes
Chronic haemolytic anaemia drives compensatory marrow hyperplasia (red marrow expansion), resulting in:
| Skeletal Change | Description |
|---|
| Medullary widening | Expansion of marrow space → cortical thinning |
| Osteopenia | Generalised bone weakness; predisposition to fractures |
| Coarsened trabeculae | Loss of corticomedullary differentiation on X-ray |
| Biconcave vertebrae | Weakened end plates compress; "codfish" appearance |
| H-shaped vertebrae | Central end-plate infarction (see Fig 5) |
| "Bone-within-a-bone" | Periosteal and endosteal cortical thickening from chronic ischaemia |
| Growth disturbance | Epiphyseal growth plate infarction → limb length discrepancy |
Orthopaedic Complication 7: Gouty Arthritis
- Chronic haemolysis → increased nucleic acid turnover → hyperuricaemia
- Acute gouty attacks can occur, particularly in large joints
- Treat as standard gout: colchicine, NSAIDs (use cautiously in SCD), allopurinol for prophylaxis
Part III — Investigations & Evaluation
Haematological & Biochemical
| Test | Finding in SCD |
|---|
| Full Blood Count | Hb 6–9 g/dL; MCV normal/low; reticulocytosis (10–20%) |
| Peripheral Blood Smear | Sickle cells, target cells, Howell-Jolly bodies (asplenia), nucleated RBCs, polychromasia |
| Haemoglobin Electrophoresis | Definitive diagnosis: HbS >80% (HbSS); HbA absent in HbSS; HbF variable |
| HPLC (High-Performance Liquid Chromatography) | Gold standard for HbS quantification |
| Reticulocyte count | Elevated (haemolysis marker) |
| LDH / Bilirubin | Elevated (haemolysis) |
| Urine | Haemoglobinuria during crisis |
| ESR / CRP / WBC | Elevated in osteomyelitis > bone infarction |
| Blood cultures | Essential if fever present (septicaemia from asplenia) |
| Uric acid | Elevated → gout risk |
Imaging
| Modality | Role |
|---|
| Plain X-ray | First line: H-shaped vertebrae, AVN stages, periosteal reaction, dactylitis, cortical thickening |
| MRI | Gold standard for: early AVN, bone marrow oedema, distinguishing infarction from osteomyelitis, soft tissue involvement |
| Bone scan (Tc-99m) | Sensitive for infarction (may show photopenic "cold" areas early); confirms osteomyelitis (hot in all 3 phases) |
| CT | Assesses cortical destruction, sequestra, extent of femoral head collapse |
| Ultrasound | Joint effusion in septic arthritis |
| DEXA scan | Assess bone mineral density (osteopenia/osteoporosis) |
Neonatal Screening
- Mandatory newborn screening in most countries: heel-prick blood spot HPLC/electrophoresis
- Early diagnosis enables prophylactic penicillin before first sickling crisis
Part IV — Treatment
A. General / Disease-Modifying Treatment
| Treatment | Mechanism / Role |
|---|
| Hydroxyurea | Increases HbF production → dilutes HbS → reduces sickling; reduces frequency of crises by ~50%; reduces ACS, stroke, hospitalisations; first-line disease-modifying agent |
| Prophylactic penicillin | Started at 2–3 months of age; prevents pneumococcal sepsis from asplenia; continued until age 5 (some continue lifelong) |
| Folic acid | Supplements demands of chronic haemolysis |
| Vaccinations | Pneumococcal (PCV + PPSV23), meningococcal, Hib, influenza — critical for asplenic patients |
| Blood transfusion | Simple transfusion: acute anaemia, ACS, stroke; Exchange transfusion: acute chest syndrome, stroke, pre-operatively (reduces HbS <30%) |
| Stem cell transplantation | Potentially curative; limited by donor availability; best in children with severe disease and HLA-matched sibling donor |
| Voxelotor | Inhibits HbS polymerisation by increasing Hb oxygen affinity |
| Crizanlizumab | Anti-P-selectin antibody; reduces frequency of VOC |
| L-glutamine | Reduces oxidative damage to RBCs |
| Gene therapy | Emerging; autologous stem cell gene correction (LentiGlobin/Zynteglo) |
B. Orthopaedic-Specific Treatment
Acute Vaso-Occlusive Bone Crisis
- Hydration (IV fluids — reverses sickling, reduces viscosity)
- Analgesia: stepwise — paracetamol → NSAIDs → weak opioids → strong opioids (IV morphine/PCA for severe crisis)
- Warmth of affected extremity
- Oxygen supplementation if hypoxic
- Treat precipitating cause (infection, dehydration)
Osteomyelitis
- IV antibiotics: vancomycin + ciprofloxacin (covers Salmonella and S. aureus)
- Blood cultures and bone biopsy pre-treatment
- Surgical debridement and drainage if abscess, sequestrum, or no response to antibiotics
Avascular Necrosis (AVN)
| Stage | Treatment |
|---|
| Precollapse (Ficat I–II) | Non-weight bearing; core decompression (±bone marrow injection); physiotherapy |
| Stage III (early collapse) | Core decompression + vascularised fibular graft; rotational osteotomy in selected young patients |
| Stage IV (established collapse) | Total Hip Arthroplasty (THA) — gold standard; technically challenging (sclerotic/narrow canal); use of cementless stems preferred |
| Humeral head AVN | Shoulder replacement (hemiarthroplasty or TSA) for advanced cases |
Peri-operative SCD precautions (for any orthopaedic surgery):
- Pre-operative exchange transfusion (reduce HbS to <30%)
- Avoid: hypoxia, hypothermia, hypovolaemia, tourniquet use (promotes sickling)
- Adequate post-op hydration and oxygenation
- Early mobilisation
Dactylitis
- Analgesia, hydration, warmth; antibiotics if osteomyelitis cannot be excluded
Summary Table: SCD Orthopaedic Complications at a Glance
| Complication | Key Feature | Most Common Organism | Key Investigation | Definitive Treatment |
|---|
| Dactylitis | Age <5; hand/foot swelling | — | X-ray, clinical | Analgesia, hydration |
| Bone infarction | Diaphyseal bone pain; crisis | — | MRI | Analgesia, hydration |
| Osteonecrosis (AVN) | Femoral/humeral head | — | MRI (early); X-ray (late) | Core decompression → THA |
| Osteomyelitis | Diaphyseal; multifocal | Salmonella > S. aureus | MRI, bone biopsy + culture | Vancomycin + ciprofloxacin ± surgery |
| Septic arthritis | Hot, swollen joint | S. aureus, Streptococcus | Joint aspiration, MRI | Washout + IV antibiotics |
| Marrow hyperplasia | H-vertebrae, osteopenia | — | X-ray, MRI, DEXA | Hydroxyurea, calcium/Vit D |
| Gouty arthritis | Large joint attacks | — | Uric acid, joint aspirate | Colchicine, allopurinol |
Key Sources:
- Harrison's Principles of Internal Medicine, 22nd ed. (2025), Ch. 386 — Arthropathies Associated with Haemoglobinopathies
- Grainger & Allison's Diagnostic Radiology, Ch. 66 — Haematological Bone Disease
- Rosen's Emergency Medicine, Ch. 125 — Osteomyelitis in Sickle Cell Disease
- Mulholland and Greenfield's Surgery, 7th ed., Ch. 14 — Sickle Cell Disease
- Robbins, Cotran & Kumar Pathologic Basis of Disease, Ch. 12 — Osteonecrosis